[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Ms. Melita Sun Jung", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 508886, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew W. Gengos", "age": 60, "title": "CFO & Head of Corporate Development", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caryn Gordon McDowell J.D.", "age": 54, "title": "Chief Legal Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Robin  Andrulevich", "age": 58, "title": "Chief People Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey R. Jasper Ph.D.", "title": "Senior Vice President of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil T. Kuriakose M.D.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Harris", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Sieminski", "title": "Senior Vice President of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Kanter", "title": "Senior VP of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yasameen  Qazen", "title": "Senior VP of Regulatory Affairs & Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.03, "open": 8.01, "dayLow": 8.01, "dayHigh": 8.32, "regularMarketPreviousClose": 8.03, "regularMarketOpen": 8.01, "regularMarketDayLow": 8.01, "regularMarketDayHigh": 8.32, "payoutRatio": 0.0, "beta": -0.035, "forwardPE": -5.920863, "volume": 702836, "regularMarketVolume": 702836, "averageVolume": 1088690, "averageVolume10days": 920410, "averageDailyVolume10Day": 920410, "bid": 5.9, "ask": 10.36, "bidSize": 2, "askSize": 2, "marketCap": 720215872, "fiftyTwoWeekLow": 1.865, "fiftyTwoWeekHigh": 8.429, "allTimeHigh": 28.36, "allTimeLow": 1.45, "fiftyDayAverage": 6.9328, "twoHundredDayAverage": 4.686225, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 405903936, "profitMargins": 0.0, "floatShares": 52506629, "sharesOutstanding": 87511048, "sharesShort": 8308078, "sharesShortPriorMonth": 7119785, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.0949, "heldPercentInsiders": 0.0029699998, "heldPercentInstitutions": 1.04386, "shortRatio": 7.02, "shortPercentOfFloat": 0.095, "impliedSharesOutstanding": 87511048, "bookValue": 3.49, "priceToBook": 2.358166, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -91745000, "trailingEps": -1.03, "forwardEps": -1.39, "enterpriseToEbitda": -3.848, "52WeekChange": 0.048407674, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 8.23, "targetHighPrice": 34.0, "targetLowPrice": 7.44, "targetMeanPrice": 17.805, "targetMedianPrice": 16.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 315444992, "totalCashPerShare": 3.605, "ebitda": -105483000, "totalDebt": 1133000, "quickRatio": 24.427, "currentRatio": 24.698, "debtToEquity": 0.371, "returnOnAssets": -0.23966, "returnOnEquity": -0.35022998, "freeCashflow": -48282248, "operatingCashflow": -74359000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TERN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Terns Pharmaceuticals, Inc.", "longName": "Terns Pharmaceuticals, Inc.", "regularMarketChangePercent": 2.49066, "regularMarketPrice": 8.23, "marketState": "CLOSED", "exchange": "NMS", "messageBoardId": "finmb_558294166", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": 1.9429, "postMarketPrice": 8.3899, "postMarketChange": 0.159901, "regularMarketChange": 0.2, "regularMarketDayRange": "8.01 - 8.32", "corporateActions": [], "postMarketTime": 1759535992, "regularMarketTime": 1759521600, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1088690, "fiftyTwoWeekLowChange": 6.365, "fiftyTwoWeekLowChangePercent": 3.4128685, "fiftyTwoWeekRange": "1.865 - 8.429", "fiftyTwoWeekHighChange": -0.19900036, "fiftyTwoWeekHighChangePercent": -0.023609012, "fiftyTwoWeekChangePercent": 4.8407674, "earningsTimestampStart": 1762977600, "earningsTimestampEnd": 1762977600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.03, "epsForward": -1.39, "epsCurrentYear": -1.15175, "priceEpsCurrentYear": -7.1456475, "fiftyDayAverageChange": 1.2971997, "fiftyDayAverageChangePercent": 0.18711051, "twoHundredDayAverageChange": 3.5437746, "twoHundredDayAverageChangePercent": 0.7562109, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "displayName": "Terns Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]